- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07570446
AUTONOMOUS DISORDERS IN CMT (CMT-autonom)
Hereditary neuropathies are a phenotypically and genetically heterogeneous group of disorders. One of the most common forms is Charcot-Marie-Tooth neuropathy (CMT), which can be further divided into demyelinating (CMT1) and axonal (CMT2) neuropathies, as well as various pathogenic genetic variants. In addition to the clinically predominant motor and sensory deficits, symptoms of the autonomic nervous system have also been described in patients with CMT, often leading to significant limitations in daily functioning and quality of life. However, little is known about the prevalence and extent of autonomic dysfunction in CMT patients.
In this study, patients with CMT will be assessed for the presence, severity, and characteristics of autonomic dysfunction using questionnaires and non-invasive diagnostic methods. Furthermore, diagnosis, genotype, and individual disease data-such as disease duration, severity of neurological impairment, and comorbidities-will be collected from patient records.
The aim of this study is to evaluate and characterize autonomic dysfunction in patients with CMT. It seeks to determine how frequently autonomic dysfunction occurs in CMT, which areas of the autonomic nervous system are most commonly affected, whether risk factors exist, and what differences can be observed between the various CMT subtypes. The findings of this study are expected to provide new insights into the role of autonomic dysfunction in CMT, ultimately contributing to improved care and treatment for affected patients.
Studieoversigt
Status
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Michael W Sereda, Prof. MD
- Telefonnummer: +49 551 3964162
- E-mail: sereda@mpinat.mpg.de
Studiesteder
-
-
Lower Saxony
-
Göttingen, Lower Saxony, Tyskland, 37075
- Rekruttering
- University Medical Centre
-
Kontakt:
- Sandrin Plewe
- Telefonnummer: +49 551 3964162
- E-mail: sandrin.plewe@med.uni-goettingen.de
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Clinical CMT Diagnosis / Anamnestically Healthy Control Group
- Genetic confirmation of CMT in adult patients
- Ability to achieve the outcome measure at baseline
- Age between 18 and 65 years
- Capacity of all study participants to consent and signed informed consent, - including patient or participant information and consent form
Exclusion Criteria:
- Pregnancy or breastfeeding period
- Other relevant neurological or psychiatric disorders, acute or in the past history
- Presence of a serious previous internal disease
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
CMT -patienter
|
|
Kontroller
Sunde aldersmatchede kontroller
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
COMPASS 31
Tidsramme: baseline
|
validated questionaire
|
baseline
|
|
electrophysiological measurement
Tidsramme: baseline
|
Validated electrophysiological examinations including the sympathetic skin reflex, the Schellong test, and heart rate variability measurement
|
baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
muscle strength
Tidsramme: baseline
|
baseline
|
|
|
neurography
Tidsramme: baseline
|
Examinations measuring the electrical activity and conductivity of nerves, which are used to diagnose nerve damage or diseases.
|
baseline
|
|
nerve sonography
Tidsramme: at visit
|
at visit
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Sygdomme i nervesystemet
- Neuromuskulære sygdomme
- Genetiske sygdomme, medfødte
- Sygdomme i det perifere nervesystem
- Neurodegenerative sygdomme
- Medfødte abnormiteter
- Heredodegenerative lidelser, nervesystem
- Misdannelser i nervesystemet
- Polyneuropatier
- Arvelig sensorisk og motorisk neuropati
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Charcot-Marie-Tooth sygdom
Andre undersøgelses-id-numre
- 17/05/2024_C2
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med CMT - Charcot-Marie-Tooth Disease
-
University Medical Center GoettingenAssistance Publique Hopitaux De MarseilleRekrutteringCMT - Charcot-Marie-Tooth Disease | CMT1A | CMT (Charcot Marie tandsygdom) | CMT 1A | CMTTyskland
-
University Medical Center GoettingenRekrutteringCharcot Marie tandsygdom | CMT (Charcot Marie tandsygdom) | CMT | Charcot Marie tandsygdom (CMT)Tyskland
-
University Medical Center GoettingenRekrutteringCMT - Charcot-Marie-Tooth Disease | CMT1A | CMT (Charcot Marie tandsygdom) | CMT 1ATyskland
-
Hereditary Neuropathy FoundationRekrutteringCharcot-Marie-Tooth sygdom | Charcot-Marie-Tooth sygdom, type IA | Charcot-Marie-Tooth sygdom type 2A | Charcot-Marie-Tooth | Charcot-Marie-Tooth sygdom, type IB | Charcot-Marie-Tooth sygdom type 2 | Charcot-Marie-Tooth sygdom, type 2C | Charcot-Marie-Tooth sygdom type 2A2B | Charcot-Marie-Tooth sygdom... og andre forholdForenede Stater
-
n-Lorem FoundationThe University of Texas Health Science Center, HoustonTilmelding efter invitationCharcot-Marie-Tooth sygdom type 2DForenede Stater
-
Elpida Therapeutics SPCIkke rekrutterer endnuCharcot-Marie-Tooth Sygdom Type 4J
-
University of South FloridaNational Institute of Neurological Disorders and Stroke (NINDS); University...AfsluttetMedfødte abnormiteter | Genetiske sygdomme, medfødte | Nervekompressionssyndromer | Arvelig sensorisk og motorisk neuropati | Heredodegenerative lidelser, nervesystem | Tandsygdomme | Charcot Marie tandsygdom (CMT)Forenede Stater
-
Applied Therapeutics, Inc.Trukket tilbageCharcot-Marie-tandsygdom med sorbitol dehydrogenase-mangel (CMT-Sord)Forenede Stater, Frankrig, Tyskland, Spanien, Tyrkiet (Türkiye), Australien, Italien
-
Bopha ChreaRekruttering
-
Universidad de La FronteraRekrutteringEffekter af resistensøvelser i arvelig sensorisk-motorisk neuropati (Charcot-Marie-tandsygdom) (PNP)Polyneuropati | Charcot Marie tandsygdom (CMT)Chile